In a genetic preclinical study, embryonic GIPR knockout mice fed a high-fat diet were protected from obesity, supporting the role of GIPR antagonism as a method to promote weight loss and prevent weight gain (67)
Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides
For example, KI models may permit more relevant gene expression patterns in rodent models of AD
2019 Jun:225:378-387
Madsen, T
for replenishment of electrolytes, trace elements, energy, protein and vitamins for athletes or convalescent animals It is a restorer of internal medium for the replacement and/or the maintenance of lost electrolytes during the exercise, training or competitions, dehydration, diarrheas, convalescences, loss or accentuated diminution of appetite, etc
